Q5098 Injection ustekinumab-srlf, 1 milligrams
Also known as: Wintivo injection, ustekinumab-srlf
Injection of ustekinumab-srlf (Wintivo) biosimilar per 1 milligram, a tumor necrosis factor inhibitor.
In Plain Language
immune system medication injection; biologic drug therapy
Clinical Context
Used for treating inflammatory conditions such as psoriasis, psoriatic arthritis, and Crohn's disease.
RVU Information
CPT Q5098 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5098?
CPT Q5098 (Injection ustekinumab-srlf, 1 milligrams) is a Q Codes code. Injection of ustekinumab-srlf (Wintivo) biosimilar per 1 milligram, a tumor necrosis factor inhibitor.
Is Q5098 covered by insurance?
Q5098 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for treating inflammatory conditions such as psoriasis, psoriatic arthritis, and Crohn's disease.
When is CPT Q5098 used?
Used for treating inflammatory conditions such as psoriasis, psoriatic arthritis, and Crohn's disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.